Reversible hepatotoxicity of paroxetine in a patient with major depression

C. Helmchen*, R. J. Boerner, R. Meyendorf, U. Hegerl

*Korrespondierende/r Autor/-in für diese Arbeit
25 Zitate (Scopus)

Abstract

Selective serotonin reuptake inhibitors (SSRIs) are becoming widely used because of their favorable side-effect profile and their safety in overdose. We report about a patient with recurring major depression (DSM-IIIR) who was treated with paroxetine and developed a severe hepatotoxic reaction, which was reversed after withdrawal of the drug. Individual, patient-related causes for this side-effect were not found. To our knowledge, this is the first published case of a probably paroxetine-induced severe hepatotoxicity. Hepatotoxicity should be taken into account as a rare complication that may occur not only with tricyclic antidepressants (TCAs) but also with SSRIs.

OriginalspracheEnglisch
ZeitschriftPharmacopsychiatry
Jahrgang29
Ausgabenummer6
Seiten (von - bis)223-226
Seitenumfang4
ISSN0176-3679
DOIs
PublikationsstatusVeröffentlicht - 01.01.1996

Strategische Forschungsbereiche und Zentren

  • Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Reversible hepatotoxicity of paroxetine in a patient with major depression“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren